Oppenheimer Maintains Outperform on Bioceres Crop Solutions, Lowers Price Target to $13

Benzinga · 10/21 15:25
Oppenheimer analyst Kristen Owen maintains Bioceres Crop Solutions (NASDAQ:BIOX) with a Outperform and lowers the price target from $16 to $13.